Clinical Trial Update: Study EvAluating Genotypes While Using Lucentis 2 [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating genotypes while using Lucentis for age-related macular degeneration; study completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: University of California, San Diego | Conditions: Age-Related Macular Degeneration | Phase 4 | Status: COMPLETED | Results posted: 2019-08-14